Anthrax
Heteropolymer data presented at international anthrax meeting
Published in Vaccine Weekly, April 30th, 2003
"The data show that our anthrax drug works in animals to protect them from the harmful effects of anthrax toxin," said Stephen Sudovar, president and CEO of Elusys. "These trials also demonstrate that the heteropolymer technology can take antibodies that may be harmful on their own and make them beneficial."
Elusys is developing a heteropolymer (HP) to remove anthrax toxin from the bloodstream. The toxin is the component of anthrax that can seriously harm and kill people. Currently there are few useful...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
Source: Vaccine Weekly (2003-04-30)
More Articles from Vaccine Weekly
- Anthrax
Venezuelan equine encephalitis virus used as vector in anthrax vaccine - Hepatitis B Vaccine
Hepatitis B vaccination program a resounding success in Taiwan - Influenza Vaccine
Novel liposomal influenza subunit vaccine safe and effective in young adults - Pediatric Vaccine
Childhood vaccines do not cause allergic or autoimmune disease - Smallpox Vaccine
Progressive vaccinia more likely in patients with cell-mediated immunodeficiency - Type 1 Diabetes
Inactivated coxsackievirus vaccine prevents onset of type 1 diabetes in mice - More from this issue of Vaccine Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
